EANS-Voting Rights
Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act - Seite 2
| | | |Number of voting | |
| | | | rights that may | |
| | | | be | |
| Type of |Expiration Date|Exercise Period|acquired if the | % of voting |
| instrument | | | instrument is | rights |
| | | | exercised | |
|_____________|_______________|_______________|_________________|______________|
| | | SUBTOTAL B.1 | | |
|_____________|_______________|_______________|_________________|______________|
_____________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG |
|2018 |
|_____________________________________________________________________________|
| Type of | Expiration | Exercise | Physical / | Number of |% of voting |
|instrument | Date | Period | Cash |voting rights| rights |
|___________|____________|___________|_Settlement__|_____________|____________|
| | | |SUBTOTAL B.2 | | |
|___________|____________|___________|_____________|_____________|____________|
8. Information in relation to the person subject to the notification obligation:
Person subject to the notification obligation is not controlled by any natural
person or legal entity and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying) issuer.
9. In case of proxy voting
Date of general meeting: -
Voting rights after general meeting: - is equivalent to - voting rights.
10. Additional comments:
The voting rights held by Erste Asset Management GmbH as stated in section 8 are
not held directly but by the investment funds managed by the management company.
They are therefore not holdings of the management company.
Note of the Issuer: This is a translation of the received shareholder
notification in German language. The translation into English is not binding.
Further inquiry note:
Dr. Eva Prieschl-Grassauer
Chief Scientific Officer, Marinomed
Veterinärplatz 1, 1210 Vienna, Austria
T +43 (0)1 250 77 4460
E-Mail: eva.prieschl@marinomed.com
http://www.marinomed.com
Roland Mayrl
Managing Partner, Metrum Communications
Bauernmarkt 10/19, 1010 Vienna, Austria
T +43 (0) 1 504 69 87 331
E-Mail: r.mayrl@metrum.at
http://www.metrum.at
end of announcement euro adhoc
--------------------------------------------------------------------------------
issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
2 im Artikel enthaltene WerteIm Artikel enthaltene Werte